An in vivo model for thyroid regeneration and folliculogenesis-Reference-Cited by-同舟云学术

An in vivo model for thyroid regeneration and folliculogenesis

Published:2018-06-26 Issue:9 Volume:98 Page:1126-1132
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Iwadate Manabu,Takizawa Yoshinori,Shirai Yo-Taro,Kimura Shioko^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41374-018-0068-x.pdf

Reference31 articles.

1. Coclet J, Foureau F, Ketelbant P, et al. Cell population kinetics in dog and human adult thyroid. Clin Endocrinol. 1989;31:655–65.

2. Capen CC. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol. 1997;25:39–48.

3. Capen CCMartin SL. The effects of xenobiotics on the structure and function of thyroid follicular and C-cells. Toxicol Pathol. 1989;17:266–93.

4. Chen CY, Kimura H, Landek-Salgado MA, et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology. 2009;150:492–9.

5. Johansen R, Gardner RE, Galante M, et al. An experimental study of thyroid regeneration following subtotal thyroidectomy. Surg Gynecol Obstet. 1951;93:303–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAF^V600E‐associated thyroid carcinoma;Clinical and Translational Medicine;2024-05

2. Establishment and Characterization of Amitrole-Induced Mouse Thyroid Adenomatous Nodule-Derived Cell Lines;Thyroid®;2024-01-24

3. Progress Toward and Challenges Remaining for Thyroid Tissue Regeneration;Endocrinology;2023-08-28

4. Thyroid hypogenesis is associated with a novel AKT3 germline variant that causes megalencephaly and cortical malformation;Human Genome Variation;2022-06-03

5. Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors;Nature Communications;2022-03-24